Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
24.01
-0.29 (-1.19%)
BSENSE

Dec 19

BSE+NSE Vol: 90.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
15.83
15.83
Share Warrants & Outstandings
Total Reserve
133.15
119.96
Shareholder's Funds
148.98
135.79
Minority Interest
0.00
0.00
Long-Term Borrowings
9.23
13.35
Secured Loans
8.70
12.44
Unsecured Loans
0.53
0.91
Deferred Tax Assets / Liabilities
9.82
12.09
Other Long Term Liabilities
6.8
8.41
Long Term Trade Payables
0.00
0.00
Long Term Provisions
0.00
0.00
Total Non-Current Liabilities
25.84
33.85
Current Liabilities
Trade Payables
91.15
66.16
Other Current Liabilities
27.41
22.31
Short Term Borrowings
71.94
74.60
Short Term Provisions
1.10
0.99
Total Current Liabilities
191.60
164.06
Total Liabilities
366.42
333.70
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
269.95
232.39
Less: Accumulated Depreciation
122.08
107.42
Less : Impairment of Assets
0.00
0.00
Net Block
147.87
124.97
Lease Adjustment
0.00
0.00
Capital Work in Progress
0.00
0.00
Intangible assets under development
2.69
7.74
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
0.00
0.00
Long Term Loans & Advances
2.01
2.29
Other Non Current Assets
0.00
0.00
Total Non-Current Assets
167.44
157.70
Current Assets Loans & Advances
Current Investments
0.00
0.00
Inventories
138.80
123.64
Sundry Debtors
39.07
27.94
Cash and Bank
2.59
1.19
Other Current Assets
1.64
1.69
Short Term Loans and Advances
16.88
21.54
Total Current Assets
198.98
176.00
Net Current Assets (Including Current Investments)
7.38
11.94
Total Current Assets Excluding Current Investments
198.98
176.00
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
366.42
333.70
Contingent Liabilities
34.64
11.96
Total Debt
81.33
87.95
Book Value per share (adjusted)
89.65
85.79
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -7.71% vs NA in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -19.14% vs NA in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 18.32% vs NA in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 13.06% vs NA in Mar 2024

Compare Balance Sheet Results of Mangalam Drugs
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
15.83
12.47
3.36
26.94%
Share Warrants & Outstandings
Total Reserve
133.15
108.81
24.34
22.37%
Shareholder's Funds
148.98
121.28
27.70
22.84%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
9.23
0.00
9.23
0.00%
Secured Loans
8.70
0.00
8.70
0.00%
Unsecured Loans
0.53
0.00
0.53
0.00%
Deferred Tax Assets / Liabilities
9.82
0.41
9.41
2,295.12%
Other Long Term Liabilities
6.80
0.00
6.80
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.63
-0.63
-100.00%
Total Non-Current Liabilities
25.84
1.05
24.79
2,360.95%
Current Liabilities
Trade Payables
91.15
1.58
89.57
5,668.99%
Other Current Liabilities
27.41
1.52
25.89
1,703.29%
Short Term Borrowings
71.94
0.00
71.94
0.00%
Short Term Provisions
1.10
0.00
1.10
0.00%
Total Current Liabilities
191.60
3.10
188.50
6,080.65%
Total Liabilities
366.42
125.42
241.00
192.15%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
269.95
91.44
178.51
195.22%
Less: Accumulated Depreciation
122.08
35.34
86.74
245.44%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
147.87
56.10
91.77
163.58%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.08
-0.08
-100.00%
Intangible assets under development
2.69
0.00
2.69
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
15.42
-15.42
-100.00%
Long Term Loans & Advances
2.01
0.00
2.01
0.00%
Other Non Current Assets
0.00
0.39
-0.39
-100.00%
Total Non-Current Assets
167.44
71.99
95.45
132.59%
Current Assets Loans & Advances
Current Investments
0.00
28.70
-28.70
-100.00%
Inventories
138.80
3.20
135.60
4,237.50%
Sundry Debtors
39.07
8.79
30.28
344.48%
Cash and Bank
2.59
0.41
2.18
531.71%
Other Current Assets
1.64
5.32
-3.68
-69.17%
Short Term Loans and Advances
16.88
7.01
9.87
140.80%
Total Current Assets
198.98
53.44
145.54
272.34%
Net Current Assets (Including Current Investments)
7.38
50.34
-42.96
-85.34%
Total Current Assets Excluding Current Investments
198.98
24.74
174.24
704.28%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
366.42
125.42
241.00
192.15%
Contingent Liabilities
34.64
0.00
34.64
0.00%
Total Debt
81.33
0.00
81.33
0.00%
Book Value per share (adjusted)
89.65
97.25
-7.60
-7.81%
Annual - Borrowings
Borrowings 81.17 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -7.71% vs NA in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 6.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -19.14% vs NA in Mar 2024

Annual - Fixed Assets
Fixed Assets 147.87 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.32% vs NA in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024

Annual - Current Assets
Current Assets 198.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.06% vs NA in Mar 2024